Elan Drug Technologies Articles

Elan cashes in 76% chunk of its Alkermes stake for $381 million; Roche updates on Illumina bid

14 March 2012

Alkermes completes Elan DT buy; signs manufacturing deal

19 September 2011

Alkermes shareholders vote in favor of merger with Elan Drug Technology

9 September 2011

Elan Drug Tech to merge into Alkermes in $960 million deal to create CNS leader

9 May 2011

Elan plans to retire $500 million of debt; says time not right to sell EDT; updates on Alzheimer’s drug

10 August 2010

Elan again mulls hiving off its drug delivery business as separate unit; chairman to retire

20 April 2010

Elan reports smaller loss for 2009, predicting operating profit in 2010

11 February 2010

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end